Sesen Bio, Inc. announced the strengthening of its medical team with the hiring of Dominika Kowalski as Senior Director of Global Drug Safety. Ms. Kowalski?s hiring demonstrates Sesen Bio?s strong commitment to and continued focus on the development of Vicineum? for the treatment of BCG-unresponsive non-muscle invasive bladder cancer. Ms. Kowalski brings over 14 years of drug safety experience in the pharmaceutical industry supporting both marketed and investigational products. She previously worked at Horizon Therapeutics, Abbott and AbbVie, where she managed safety surveillance, preparation of periodic safety reports and adherence to local and global authority requirements.